Triterpenoids of Ganoderma lucidum inhibited S180 sarcoma and H22 hepatoma in mice by regulating gut microbiota.

Ganoderma lucidum

OncologyImmune supportMetabolic healthGut & microbiome

SpeciesReishi, Lingzhi

JournalHeliyon

Year2023

Metadata-grounded summary

Article summary

Metadata-grounded summary: This research article indexes research on Ganoderma lucidum in Heliyon in 2023. MycoData maps the paper to oncology, immune support, metabolic health, gut & microbiome based on its title, species context, article metadata, and study classification.

Citation

Wang J, Pu J, Zhang Z, Feng Z, Han J, Su X, et al. (2023). Triterpenoids of Ganoderma lucidum inhibited S180 sarcoma and H22 hepatoma in mice by regulating gut microbiota. Heliyon https://doi.org/10.1016/j.heliyon.2023.e16682 PMID: 37484292

Open citation